Olivia Belbin Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau Universitat Autònoma de Barcelona Biography Publications Institution JoVE Articles Olivia Belbin has not added a biography. If you are Olivia Belbin and would like to personalize this page please email our Author Liaison for assistance. Publications Myelin Loss in C9orf72 Hexanucleotide Expansion Carriers Journal of Neuroscience Research. Jun, 2022 | Pubmed ID: 35766328 Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome JAMA Network Open. 05, 2022 | Pubmed ID: 35604690 Multimarker Synaptic Protein Cerebrospinal Fluid Panels Reflect TDP-43 Pathology and Cognitive Performance in a Pathological Cohort of Frontotemporal Lobar Degeneration Molecular Neurodegeneration. 04, 2022 | Pubmed ID: 35395770 Blood Amyloid and Tau Biomarkers As Predictors of Cerebrospinal Fluid Profiles Journal of Neural Transmission (Vienna, Austria : 1996). 02, 2022 | Pubmed ID: 35169889 Fluid Markers of Synapse Degeneration in Synucleinopathies Journal of Neural Transmission (Vienna, Austria : 1996). 02, 2022 | Pubmed ID: 35147800 The Aβ1-42/Aβ1-40 Ratio in CSF is More Strongly Associated to Tau Markers and Clinical Progression Than Aβ1-42 Alone Alzheimer's Research & Therapy. 02, 2022 | Pubmed ID: 35105351 Neuropathology of a Patient with Alzheimer Disease Treated with Low Doses of Verubecestat Neuropathology and Applied Neurobiology. 04, 2022 | Pubmed ID: 34825396 Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies Frontiers in Neurology. 2021 | Pubmed ID: 35115992 Plasma Glial Fibrillary Acidic Protein and Neurofilament Light Chain for the Diagnostic and Prognostic Evaluation of Frontotemporal Dementia Translational Neurodegeneration. 12, 2021 | Pubmed ID: 34893073 Phosphorylated Tau181 in Plasma As a Potential Biomarker for Alzheimer's Disease in Adults with Down Syndrome Nature Communications. 07, 2021 | Pubmed ID: 34262030 Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome JAMA Neurology. 08, 2021 | Pubmed ID: 34228042 VAMP-2 is a Surrogate Cerebrospinal Fluid Marker of Alzheimer-related Cognitive Impairment in Adults with Down Syndrome Alzheimer's Research & Therapy. 06, 2021 | Pubmed ID: 34183050 Use of Plasma Biomarkers for AT(N) Classification of Neurodegenerative Dementias Journal of Neurology, Neurosurgery, and Psychiatry. 11, 2021 | Pubmed ID: 34103344 Genetic Variants in Glutamate-, Aβ-, and Tau-related Pathways Determine Polygenic Risk for Alzheimer's Disease Neurobiology of Aging. 05, 2021 | Pubmed ID: 33303219 Cerebrospinal Fluid Profile of NPTX2 Supports Role of Alzheimer's Disease-related Inhibitory Circuit Dysfunction in Adults with Down Syndrome Molecular Neurodegeneration. 08, 2020 | Pubmed ID: 32807227 Motor Cortex Transcriptome Reveals Microglial Key Events in Amyotrophic Lateral Sclerosis Neurology(R) Neuroimmunology & Neuroinflammation. 09, 2020 | Pubmed ID: 32669313 Clinical and Biomarker Changes of Alzheimer's Disease in Adults with Down Syndrome: a Cross-sectional Study Lancet (London, England). 06, 2020 | Pubmed ID: 32593336 The Sant Pau Initiative on Neurodegeneration (SPIN) Cohort: A Data Set for Biomarker Discovery and Validation in Neurodegenerative Disorders Alzheimer's & Dementia (New York, N. Y.). 2019 | Pubmed ID: 31650016 Nanoscale Structure of Amyloid-β Plaques in Alzheimer's Disease Scientific Reports. 03, 2019 | Pubmed ID: 30914681 Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid Molecular & Cellular Proteomics : MCP. 03, 2019 | Pubmed ID: 30606734 Weight Loss in the Healthy Elderly Might Be a Non-cognitive Sign of Preclinical Alzheimer's Disease Oncotarget. Dec, 2017 | Pubmed ID: 29285207 Synaptic Phosphorylated α-synuclein in Dementia with Lewy Bodies Brain : a Journal of Neurology. Dec, 2017 | Pubmed ID: 29177427 YKL-40 (Chitinase 3-like I) is Expressed in a Subset of Astrocytes in Alzheimer's Disease and Other Tauopathies Journal of Neuroinflammation. 06, 2017 | Pubmed ID: 28599675 Erratum To: Genetically-controlled Vesicle-Associated Membrane Protein 1 Expression May Contribute to Alzheimer's Pathophysiology and Susceptibility Molecular Neurodegeneration. Sep, 2015 | Pubmed ID: 26399695 Genetically-controlled Vesicle-Associated Membrane Protein 1 Expression May Contribute to Alzheimer's Pathophysiology and Susceptibility Molecular Neurodegeneration. Apr, 2015 | Pubmed ID: 25881291 Autosomal-dominant Alzheimer's Disease Mutations at the Same Codon of Amyloid Precursor Protein Differentially Alter Aβ Production Journal of Neurochemistry. Jan, 2014 | Pubmed ID: 24117942 Confluence of α-synuclein, Tau, and β-amyloid Pathologies in Dementia with Lewy Bodies Journal of Neuropathology and Experimental Neurology. Dec, 2013 | Pubmed ID: 24226269 Rare Variants in Calcium Homeostasis Modulator 1 (CALHM1) Found in Early Onset Alzheimer's Disease Patients Alter Calcium Homeostasis PloS One. 2013 | Pubmed ID: 24069280 Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma Natalia Valle-Tamayo1,2, Rocío Pérez-González2,3, Gemma Chiva-Blanch4,5, Olivia Belbin1,2, Sara Serrano-Requena1,2, Sònia Sirisi1,2, Alba Cervantes González1,2, Oriol Giró4,5, Érika Sánchez-Aced1,2, Oriol Dols-Icardo1,2, Daniel Alcolea1,2, María Carmona-Iragui1,2, Amanda Jimenez4,5, Alberto Lleó1,2, Juan Fortea1,2, M. Florencia Iulita1,2 1Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, 2Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), 3Movement Disorders Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, 4Department of Endocrinology and Nutrition, Hospital Clínic de Barcelona, August Pi i Sunyer Biomedical Research Institute - IDIBAPS, 5Spanish Biomedical Research Network in Physiopathology of Obesity and Nutrition (CIBEROBN) JoVE 64107 Neuroscience
Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma Natalia Valle-Tamayo1,2, Rocío Pérez-González2,3, Gemma Chiva-Blanch4,5, Olivia Belbin1,2, Sara Serrano-Requena1,2, Sònia Sirisi1,2, Alba Cervantes González1,2, Oriol Giró4,5, Érika Sánchez-Aced1,2, Oriol Dols-Icardo1,2, Daniel Alcolea1,2, María Carmona-Iragui1,2, Amanda Jimenez4,5, Alberto Lleó1,2, Juan Fortea1,2, M. Florencia Iulita1,2 1Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, 2Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), 3Movement Disorders Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, 4Department of Endocrinology and Nutrition, Hospital Clínic de Barcelona, August Pi i Sunyer Biomedical Research Institute - IDIBAPS, 5Spanish Biomedical Research Network in Physiopathology of Obesity and Nutrition (CIBEROBN) JoVE 64107 Neuroscience